“Safe use of Interleukin-17 Inhibitors for Psoriasis and Psoriatic Arthritis in Two Patients with a History of Lymphoproliferative Disease”, J of Skin, vol. 4, no. 3, pp. 256–259, May 2020, doi: 10.25251/skin.4.3.7.